Implantable loop recorder

Implicity Continues Rapid Growth and Expansion with Hiring of Two New Senior Leaders

Retrieved on: 
Wednesday, September 28, 2022
Adoption, Idealized cognitive model, Communication, Algorithm, Implantable loop recorder, Efficiency, Workload, FDA, No. 166 Squadron RAF, Company, Heart, Medtech, Growth, European Heart Journal, Review, Philips, Industry, Heart failure, Head, Patient, CEO, Technology, Medtronic, Cardiology, ECG, St. Jude Medical, Research, Marketing, Awareness, RPM, Medical device, Electrophysiology, Implicate and explicate order

CAMBRIDGE, Mass., Sept. 28, 2022 /PRNewswire/ -- Implicity®, a leader in remote patient monitoring and cardiac data management solutions, announced its continued growth with the appointment of two new senior-level executives. Vanessa Joyce was named the Company's new Vice President of Sales for North America, and Megan Grosz was appointed Global Head of Marketing and Communications.

Key Points: 
  • Both Vanessa and Megan bring a wealth of industry knowledge to support our rapid global expansion, particularly in the U.S.where we see a dramatic rise in remote patient monitoring," said Dr. Arnaud Rosier, Electrophysiologist, CEO, and Co-founder of Implicity.
  • Vanessa Joyce comes to Implicity with more than 30 years of experience in MedTech marketing and clinical aspects ofthe Cardiac, Heart Failure, and Electrophysiology industries.
  • "I'm excited to apply my expertise and experience to establish Implicity as the primary CIED remote monitoring software solution," said Joyce.
  • Implicity proudly protects more than 70,000 patients in more than 100 medical facilities across the United States and Europe.

Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market Analysis Report 2022: Companies are Focusing on Extensive Research and Development Activities to Stay Competitive - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 2, 2022
Medical Devices, Health, Biometrics, Health Technology, Cardiology, Biotechnology, Implantable loop recorder, Hospital, Research, Degenerative disease, Cardiac output, Defibrillation, CAGR, Company, Patient, ECG, Population, Medical device

The "Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Cardiac Monitoring Devices (ECG Devices, Implantable Loop Recorders, Others), By Cardiac Rhythm Management Devices, By End User, By Region, Competition Forecast & Opportunities, 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Cardiac Monitoring Devices (ECG Devices, Implantable Loop Recorders, Others), By Cardiac Rhythm Management Devices, By End User, By Region, Competition Forecast & Opportunities, 2027" report has been added to ResearchAndMarkets.com's offering.
  • The global cardiac monitoring & cardiac rhythm management devices market is expected to grow at a steady CAGR in the forecast period, 2023-2027
    Factors such as the rise in the number of patients suffering from cardiovascular disorders and the growing geriatric population are driving the demand for the global cardiac monitoring & cardiac rhythm management devices market.
  • The global cardiac monitoring & cardiac rhythm management devices market is segmented into cardiac monitoring devices, cardiac rhythm management devices, end user, company, and regional distribution.
  • To classify and forecast global cardiac monitoring & cardiac rhythm management devices market based on cardiac monitoring devices, cardiac rhythm management devices, end user, company, and regional distribution
    To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global cardiac monitoring & cardiac rhythm management devices market
    Company Profiles: Detailed analysis of the major companies present in global cardiac monitoring & cardiac rhythm management devices market.

New Analysis from Global Industry Analysts Reveals Steady Growth for Cardiac Monitoring Devices, with the Market to Reach $8.6 Billion Worldwide by 2026

Retrieved on: 
Tuesday, June 28, 2022
GE Healthcare, Insulation monitoring device, Research, Laboratory, Intelligence, Marketing, COVID-19, Growth, Forecasting, LivaNova, COM, GIA, Boston Scientific, SAN, Implantable loop recorder, Abbott Laboratories, Medtronic, CAGR, ECG, Biotelemetry, Philips, No. 166 Squadron RAF, Players, Medical device, Pet, Others

SAN FRANCISCO, June 28, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Cardiac Monitoring Devices - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, June 28, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Cardiac Monitoring Devices - Global Market Trajectory & Analytics" .
  • Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more.
  • Preview Registry
    Amid the COVID-19 crisis, the global market for Cardiac Monitoring Devices estimated at US$5.8 Billion, is projected to reach a revised size of US$8.6 Billion by 2026, growing at a CAGR of 6.6% over the analysis period.
  • Global Industry Analysts, Inc., ( www.strategyr.com ) is a renowned market research publisher the world`s only influencer driven market research company.

IMPLICITY® to Showcase New Artificial Intelligence-based Innovations in Remote Cardiac Monitoring at HRS 2022

Retrieved on: 
Tuesday, April 19, 2022
CEO, ILR, CI, CE, Rhythm, Health status of Asian Americans, Cleveland, Research, Standard of care, Cleveland Clinic, The Valley Hospital, Associate, RCM, Cardiology, Patient, Artificial intelligence, Heart Rhythm Society, FHRS, Technology, RPM, Medtech, Solution, Workload, AI, Algorithm, Bachelor of Medicine, Bachelor of Surgery, FACC, HRS, Heart, FDA, Implantable loop recorder, MB, Knowledge, Heart Rhythm, Medical device, MD

CAMBRIDGE, Mass., April 19, 2022 /PRNewswire/ -- IMPLICITY®, a global leader in remote patient monitoring and cardiac data management solutions, is showcasing its portfolio of remote cardiac monitoring solutions at the upcoming Heart Rhythm 2022 (HRS 2022) in San Francisco, California, hosted by the Heart Rhythm Society, between April 29th and May 1st, 2022.

Key Points: 
  • CAMBRIDGE, Mass., April 19, 2022 /PRNewswire/ -- IMPLICITY , a global leader in remote patient monitoring and cardiac data management solutions, is showcasing its portfolio of remote cardiac monitoring solutions at the upcoming Heart Rhythm 2022 (HRS 2022) in San Francisco, California, hosted by the Heart Rhythm Society, between April 29th and May 1st, 2022.
  • "Using CIEDs for remote monitoring (RM) is now considered the standard of care, but they add a significant burden for clinicians because they have a high false-positive rate.
  • As part of the session, Dr. Rosier will also explain how remote patient monitoring (RPM) can support opportunities for clinical research.
  • IMPLICITYis a digital MedTech that provides a universal remote cardiac monitoring and research platform to medical centers and service companies, helping them provide the best remote care to cardiac patients.

Implantable Loop Recorders Market Size to Grow by USD 606.31 Mn| 39% of the growth to originate from North America| Technavio

Retrieved on: 
Thursday, February 24, 2022
Poseidon, Risk, FREE, Abbott Laboratories, ECG, Conditional sentence, CDC, Cardiac arrest, Partnership, Government, Growth, Prevalence, CKD, Laboratory, Projection, ESRD, Center, Arrhythmia, Thyroid, Chronic kidney disease, Stroke, Coronary artery disease, Peripheral artery disease, Korea Disease Control and Prevention Agency, Medtronic, USD, SAS, Implantable loop recorder, Boston Scientific, Degenerative disease, Patient, Sample (statistics), SRO, ILR, Kidney failure, Cardiovascular disease, Medical device, Fine chemical, Pharmaceutical industry

Resulting in market growth of USD 606.31 million from 2021 to 2026,read additional information about the market, get FREE sample report .

Key Points: 
  • Resulting in market growth of USD 606.31 million from 2021 to 2026,read additional information about the market, get FREE sample report .
  • Ltd., Vectorious Medical Technologies Ltd. among others are some of the few key vendors competing to maintain their market position in the market.
  • The implantable loop recorder helps the healthcare workers remotely monitor the patients' heartbeats for up to 3 years.
  • Apart from regions, if we look at the country-wise market growth, the US, Canada, Spain, Denmark, China, and UK will contribute to the highest market growth.

2021 Cardiac Rhythm Management Devices Medical Devices Pipeline Product Landscape Report - ResearchAndMarkets.com

Retrieved on: 
Monday, January 10, 2022
Health, Medical Devices, Cardiology, Artificial cardiac pacemaker, ICD, Implantable loop recorder, Implantable cardioverter-defibrillator, CRT, Heart, Arrhythmia, CRM, Medical device, Pharmaceutical industry

The "Cardiac Rhythm Management Devices - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cardiac Rhythm Management Devices - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.
  • This report provides comprehensive information about the Cardiac Rhythm Management Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
  • Cardiac Rhythm Management (CRM) devices are those devices which are used to restore the natural synchronized pumping rhythm of the heart.
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
    The report enables you to:
    In-depth analysis of the product's current stage of development, territory and estimated launch date

Implicity Receives FDA Clearance for AI-Powered ECG Analyzer for Implantable Loop Recorders

Retrieved on: 
Thursday, December 16, 2021
Lazarus, ILR, Cardiac electrophysiology, Arrhythmia, FDA, Solution, Implantable loop recorder, Cleveland, Algorithm, ECG, European Heart Journal, Health, XT, Noise, Fortis Healthcare, National Association Medical Staff Services, Cleveland Clinic, Ventricular fibrillation, Medtronic, CEO, Research, No. 166 Squadron RAF, Workload, Patient, Artificial intelligence, Degenerative disease, MD, LINQ, Technology, Cardiology, Medical device, Pharmaceutical industry, Implicate and explicate order

CAMBRIDGE, Mass., Dec. 16, 2021 /PRNewswire/ -- Implicity , a leader in remote patient monitoring and cardiac data management solutions, today announced FDA clearance for a novel medicalalgorithm that analyzes ECG data from Implantable Loop Recorders (ILRs).

Key Points: 
  • CAMBRIDGE, Mass., Dec. 16, 2021 /PRNewswire/ -- Implicity , a leader in remote patient monitoring and cardiac data management solutions, today announced FDA clearance for a novel medicalalgorithm that analyzes ECG data from Implantable Loop Recorders (ILRs).
  • The newly 510(k) cleared ILR ECG Analyzer is an algorithm based on artificial intelligence, representing a breakthrough innovation in the cardiology sector.
  • "This is an important step for Implicity as we expand in the US market," said Dr. Arnaud Rosier, CEO and founder of Implicity.
  • "With FDA clearance, our AI product can now be used in combination with implantable loop recorders to improve arrhythmia detection and help electrophysiologists and their teams avoid wasting time reviewing non-actionable events."

Implantable Cardiac Monitors Market Forecast to 2026 - Medtronic, Biotronik and Angel Medical Systems Dominate in Development - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 18, 2021
Health, Medical Devices, Cardiology, Online, LINQ, CAGR, EMS, Population, Atrial fibrillation, Ageing, Electronics manufacturing services, Growth, Flex (company), Technology, Acquisition, Competitive landscape, Physician, Arrhythmia, MED, CE marking, Heart, Health, Vagus nerve, United Kingdom, Electrophysiology, Patient, Report, ICM, FDA, DAIC, Implantable loop recorder, Miniaturization, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, USD, Heart failure, Medical device

The "Implantable Cardiac monitors (ICM) - Market Insights, Competitive Landscape and Market Forecast - 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Implantable Cardiac monitors (ICM) - Market Insights, Competitive Landscape and Market Forecast - 2026" report has been added to ResearchAndMarkets.com's offering.
  • This 'Implantable Cardiac Monitors (ICM)-Market Insights, Competitive Landscape and Market Forecast-2026' report delivers an in-depth understanding of the Implantable Cardiac monitors, historical and forecasted patient pool as well as the Implantable Cardiac monitors market trends in the United States, EU5 (Germany, Spain, Italy, France and the United Kingdom) and Japan.
  • The report provides an overview of Implantable Cardiac monitors and their applications, market share of the individual devices, current and forecasted Implantable Cardiac monitors market Size from 2018 to 2026, segmented by seven major markets.
  • 6 Implantable Cardiac Monitors Devices: Competitive Analysis
    8 Vagus Nerve Stimulator devices: Eligible Patient Population
    9 Implantable Cardiac Monitors Devices: Market Analysis

Global Cardiovascular Disease Monitoring and Diagnostic Devices Markets, 2021-2027 - Increasing Preference for Homecare Drives Cardiac Monitoring Devices Demand - ResearchAndMarkets.com

Retrieved on: 
Monday, August 16, 2021
Medical Devices, Health, CAGR, Cardiovascular disease, COVID-19, Monitor lizard, Growth, Implantable loop recorder, Medical device, Pharmaceutical industry, Pet

The "Cardiovascular Disease Monitoring and Diagnostic Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cardiovascular Disease Monitoring and Diagnostic Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • ECG Systems, one of the segments analyzed in the report, is projected to record a 6.2% CAGR and reach US$2.3 Billion by the end of the analysis period.
  • The U.S. Market is Estimated at $592.1 Million, While China is Forecast to Grow at 9.3% CAGR
    The Cardiovascular Disease Monitoring and Diagnostic Devices market in the U.S. is estimated at US$592.1 Million in the year 2020.
  • In the global Implantable Loop Recorders segment, USA, Canada, Japan, China and Europe will drive the 6.8% CAGR estimated for this segment.

New Study Published in JACC Clinical EP Validates that Cardiologs' AI Eliminates Nearly Two-Thirds of False Positives in Remote Monitoring for Atrial Fibrillation

Retrieved on: 
Wednesday, February 10, 2021
Medicine, Branches of biology, Cardiac electrophysiology, Clinical medicine, Atrial fibrillation, Cardiac monitoring, Implantable loop recorder, Monitoring, Electrocardiography, ILR

The findings show that Cardiologs' AI-based ECG analysis solution significantly reduces the rate of false positive atrial fibrillation (AFib) detection in remote cardiac monitoring of patients with implantable loop recorders (ILRs).

Key Points: 
  • The findings show that Cardiologs' AI-based ECG analysis solution significantly reduces the rate of false positive atrial fibrillation (AFib) detection in remote cardiac monitoring of patients with implantable loop recorders (ILRs).
  • Cardiologs and Valley Health tracked a cohort of 425 patients who received an ILR for known AFib or cryptogenic stroke.
  • Since ILRs transmit data daily, these false positives are one of the Achilles heels of remote cardiac monitoring.
  • Publication of our successful trial results in JACC EP further validates the considerable promise of our solution for the clinical community.